Gefitinib Impurity 28 | CAS 912556-91-3 - Request Quote
Gefitinib Impurity 28
| SZ CAT No: | SZ-G018046 |
| CAS No | 912556-91-3 |
| Mol.F. | C18H16Cl2FN3O2 |
| Mol.Wt. | 396.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gefitinib Impurity 28 is chemically N-(3-Chloro-4-fluorophenyl)-6-(3-chloropropoxy)-7-methoxyquinazolin-4-amine. Gefitinib Impurity 28 is supplied with detailed characterization data compliant with regulatory guideline. Gefitinib Impurity 28 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gefitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 912556-91-3
Purchase 912556-91-3
Order 912556-91-3
Enquire 912556-91-3
price of 912556-91-3
912556-91-3 Supplier
912556-91-3 Manufacturer
912556-91-3 Exporter
buy high quality Gefitinib Impurity 28
Purchase Gefitinib Impurity 28
Gefitinib Impurity 28 suppliers
Gefitinib Impurity 28 manufacturers
Gefitinib Impurity 28 price
Order Gefitinib Impurity 28
Enquire Gefitinib Impurity 28
Gefitinib Impurity 28 cost
Gefitinib Impurity 28 Supplier
Gefitinib Impurity 28 Distributor
Gefitinib Impurity 28 for Method Validation
Gefitinib Reference Standard
Gefitinib Impurity 28 for ANDA Filing
Gefitinib Impurity 28 for Forced Degradation Studies
Gefitinib Impurity 28 Identification Standards
Gefitinib Impurity 28 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


